Circulating T cells derived from Acute leukemia patients with severe therapy-induced cytopenia express a wide range of chemokine receptors

Hematology

Volumn 13, Issue 6, 2008, Pages 329-332

  Olsnes, Astrid Marta ^a   Ersvær, Elisabeth ^a   Ryningen, Anita ^a   Bruserud, Øystein ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

Acute myelogenous leukaemia; CCR; Chemotherapy; CXCR; Stem cell transplantation; T cells

Indexed keywords

ANTINEOPLASTIC AGENT; CD3 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CYTARABINE; DAUNORUBICIN; GEMTUZUMAB OZOGAMICIN; TIOGUANINE; CHEMOKINE RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELLULAR IMMUNITY; CHEMOKINESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOPENIA; DOSE RESPONSE; DRUG INDUCED DISEASE; HUMAN; HUMAN CELL; LEUKOPENIA; LYMPHOCYTE COUNT; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ALLOTRANSPLANTATION; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; CHEMISTRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; MIDDLE AGED; PANCYTOPENIA;

ADULT; AGED; ANTIGENS, CD3; CASE-CONTROL STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; MIDDLE AGED; PANCYTOPENIA; RECEPTORS, CHEMOKINE; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 60849116984     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453308X343491     Document Type: Article

References (12)

1. Smith M, Barnett M, Bassan R, Gatta G, Tondini C, Kern W. Adult acute myeloid leukaemia. Crit Rev Oncol Hematol 2004; 50(3):197-222.
2. Bruserud O, Wendelboe O. Biological treatment in acute myelogenous leukaemia: How should T-cell targeting immunotherapy be combined with intensive chemotherapy? Expert Opin Biol Ther 2001; 1(6): 1005-1016.
3. Hatfield KJ, Olsnes AM, Gjertsen BT, Bruserud O. Antiangiogenic therapy in acute myelogenous leukemia: Targeting of vascular endothelial growth factor and interleukin 8 as possible antileukemic strategies. Curr Cancer Drug Targets 2005; 5(4):229-248.
4. Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nature Immunol 2001; 2(2): 123-128.
5. Bruserud O, Ryningen A, Olsnes AM et al. Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells. Haematologica 2007; 92(3): 332-341.
6. Bruserud O, Tronstad KJ, Berge R. In vitro culture of human osteosarcoma cell lines: A comparison of functional characteristics for cell lines cultured in medium without and with fetal calf serum. J. Cancer Res Clin Oncol 2005; 131(6): 377-384.
7. Lippert U, Zachmann K, Henz BM, Neumann C. Human T lymphocytes and mast cells differentially express and regulate extra- and intracellular CXCR1 and CXCR2. Exp Dermatol 2004; 13(8): 520-525.
8. Balkwill F. Cancer and the chemokine network. Nature Rev 2004; 4(7): 540-550.
9. Anensen N, Oyan AM, Bourdon JC, Kalland KH, Bruserud O, Gjertsen BT. A distinct p53 protein isoform signature reflects the onset of induction chemotherapy for acute myeloid leukemia. Clin Cancer Res 2006; 12(13): 3985-3892.
10. Irish JM, Anensen N, Hovland R et al. Flt3 Y591 duplication and Bcl-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53. Blood 2007; 109(6): 2589-2596.
11. Bruserud O, Ehninger G, Hamann W, Pawelec G. Secretion of IL-2, IL-3, IL-4, IL-6 and GM-CSF by CD4+ and CD8+ TCR alpha beta+ T-cell clones derived early after allogeneic bone marrow transplantation. Scand J Immunol 1993; 38(1): 65-74.
12. Bruserud O. Cellular immune responses in acute leukaemia patients with severe chemotherapy-induced leucopenia; characterization of the cytokine repertoire of clonogenic T cells. Cancer Immunol Immunother 1998; 46(4): 221-228.